Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-4-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0007-1250
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
128-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7907923-Anti-Anxiety Agents,
pubmed-meshheading:7907923-Cross-Sectional Studies,
pubmed-meshheading:7907923-Flurazepam,
pubmed-meshheading:7907923-Humans,
pubmed-meshheading:7907923-Incidence,
pubmed-meshheading:7907923-Overdose,
pubmed-meshheading:7907923-Risk Factors,
pubmed-meshheading:7907923-Suicide,
pubmed-meshheading:7907923-Suicide, Attempted,
pubmed-meshheading:7907923-Switzerland
|
pubmed:year |
1994
|
pubmed:articleTitle |
Benzodiazepine fatal poisonings.
|
pubmed:publicationType |
Letter,
Comment
|